Homology Medicines Presents Preclinical Data Supporting Immunosuppression Regimen in Ongoing PKU and Hunter Syndrome Clinical Trials, and Details Optimized MLD Gene Therapy Candidate at the 19th Annual WORLDSymposium(TM) Meeting

Stock Information for Q32 Bio Inc Com

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Q32 Bio Inc Com

Homology Medicines Declares Distribution to Common Stockholders
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates EVRI, SCTL, FIXX, GRPH
Kuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law Firm
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates EGLE, FRLN, ROVR, FIXX
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SIX, FIXX, ROVR

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.